Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Jason A Keyes

CFO at BlossomHill Therapeutics, Inc. (BLSM)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys+$1K
Total bought / sold$11K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Aug 10SEC BLSMBlossomHill Therapeutics, Inc. Buy 700new position $16.00 $11K +9.3%
  • Buy

    CFO Jason A Keyes bought $11K of BLSM at $16.00 — first open-market purchase in our records; opens a new position.